Don't miss your last few chances to catch the Cure Autism Now Lecture Series this year. Events are scheduled in the San Francisco Bay Area, Philadelphia, Los Angeles and Boston. In the Bay Area, Dr. Hertz-Picciotto of the M.I.N.D. Institute will discuss autism prevalence trends in California; in Philly, Nurse Practitioner Margaret Souders will talk about sleep patterns and autism; in Los Angeles, Dr. Herbert of Mass General will present a multi-systems approach to autism; and in Boston, Dr. Blatt of Boston University will talk about his lab's work on tracking developmental delays associated with autism.
Join Dr. Irva Hertz-Picciotto, Ph.D., M.P.H. of the University of California, Davis M.I.N.D. Institute as she presents "Autism Trends in California and Early Results from the CHARGE Study" to the San Francisco/Bay Area chapter on Nov. 30. Dr. Hertz-Picciotto will discuss the aims of the study, its design and early results on children's immune status, mercury levels and expression of genes.
On Dec. 2, the Los Angeles chapter will host Martha Herbert, M.D., Ph.D., Assistant Professor of Neurology at Harvard Medical School and clinical pediatric neurologist at Massachusetts General Hospital. Dr. Herbert's lecture, "More than Genes, Brain and Behavior: Toward an Inclusive Multi-Systems Approach to Autism," will present her most current neurobiological findings in autism.
The Philadelphia chapter is pleased to host a presentation from Nurse Practitioner Margaret Souders and Maya Bucan, Ph.D., Professor of Genetics. On Dec. 7, Souders will discuss sleep patterns of children with autism and her work at Children's Hospital of Philadelphia's Regional Autism Center. Dr. Bucan will discuss autism research initiatives at the University of Pennsylvania. Rounding out the lecture series for the year will be "Neuropathology and Neurochemical Studies in the Cerebellum in Autism: Alterations in GABAergic and Glutamatergic Circuitry", presented by Dr. Gene Blatt of Boston University's School of Medicine. This lecture will be presented to the Boston chapter on Dec. 7. It will cover how Dr. Blatt's lab has constructed a series of experiments using markers for specific neurotransmitter subtypes that are designed to elucidate how this circuitry is perturbed and, in doing so, how they gain invaluable insights as to the developmental timing of autism.